Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pacific Organics is a specialized chemical synthesis company and a subsidiary of Cambridge Isotope Laboratories (CIL), based in Los Alamos, New Mexico. The company is a premier provider of stable isotope-labeled compounds, specializing in the custom synthesis of complex organic molecules labeled with Carbon-13, Nitrogen-15, and Deuterium. Its products and services are critical for researchers in the pharmaceutical, biotechnology, and diagnostic industries, supporting applications such as metabolic profiling, quantitative proteomics, and drug metabolism and pharmacokinetics (DMPK) studies. Originally an independent entity founded by experts from the Los Alamos National Laboratory, Pacific Organics was acquired by CIL in 2001 to leverage its unique expertise in high-purity isotope labeling and custom synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pacific Organics.